The reporting of safety among drug systematic reviews was poor prior to the implementation of the PRISMA harms checklist

To examine, through a cross-sectional survey, how well safety information was reported among drug systematic reviews predating PRISMA harms checklist, and explore factors associated with better reporting.

Source: Journal of Clinical Epidemiology - September 29, 2018 Category: Epidemiology Authors: Ling Li, Chang Xu, Ke Deng, Xu Zhou, Zhibin Liu, Jason W. Busse, Yan Ren, Kang Zou, Xin Sun Tags: Original Article Source Type: research